Collectively, our study demonstrates that XAF1 plays a crucial role in GBM response to TMZ therapy by directing the apoptotic switch of protective autophagy through ROS–ATM–AMPK signaling (Figure 6G). This evidence concerns the gene XAF1 and glioblastoma.